Vanguard Group Inc Rani Therapeutics Holdings, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
42Shares Held
5.93MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.5 Million0.09% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$671,2741.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$609,9490.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$411,7300.02% of portfolio
-
Stifel Financial Corp St. Louis, MO270KShares$366,8840.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $33.3M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...